CIBC Private Wealth Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-125,000
| Closed | -$513K | – | 1341 |
|
|
2022
Q1 | $513K | Hold |
125,000
| – | – | ﹤0.01% | 743 |
|
|
2021
Q4 | $446K | Hold |
125,000
| – | – | ﹤0.01% | 795 |
|
|
2021
Q3 | $455K | Hold |
125,000
| – | – | ﹤0.01% | 744 |
|
|
2021
Q2 | $545K | Hold |
125,000
| – | – | ﹤0.01% | 783 |
|
|
2021
Q1 | $514K | Hold |
125,000
| – | – | ﹤0.01% | 797 |
|
|
2020
Q4 | $499K | Hold |
125,000
| – | – | ﹤0.01% | 775 |
|
|
2020
Q3 | $338K | Hold |
125,000
| – | – | ﹤0.01% | 760 |
|
|
2020
Q2 | $344K | Hold |
125,000
| – | – | ﹤0.01% | 556 |
|
|
2020
Q1 | $295K | Hold |
125,000
| – | – | ﹤0.01% | 719 |
|
|
2019
Q4 | $588K | Hold |
125,000
| – | – | ﹤0.01% | 676 |
|
|
2019
Q3 | $418K | Hold |
125,000
| – | – | ﹤0.01% | 719 |
|
|
2019
Q2 | $411K | Hold |
125,000
| – | – | ﹤0.01% | 753 |
|
|
2019
Q1 | $379K | Hold |
125,000
| – | – | ﹤0.01% | 776 |
|
|
2018
Q4 | $340K | Hold |
125,000
| – | – | ﹤0.01% | 760 |
|
|
2018
Q3 | $420K | Hold |
125,000
| – | – | ﹤0.01% | 815 |
|
|
2018
Q2 | $323K | Hold |
125,000
| – | – | ﹤0.01% | 845 |
|
|
2018
Q1 | $275K | Hold |
125,000
| – | – | ﹤0.01% | 880 |
|
|
2017
Q4 | $249K | Hold |
125,000
| – | – | ﹤0.01% | 900 |
|
|
2017
Q3 | $405K | Hold |
125,000
| – | – | ﹤0.01% | 802 |
|
|
2017
Q2 | $403K | Hold |
125,000
| – | – | ﹤0.01% | 553 |
|
|
2017
Q1 | $355K | Hold |
125,000
| – | – | ﹤0.01% | 545 |
|
|
2016
Q4 | $291K | Sell |
125,000
-19,000
| -13% | -$36.2K | ﹤0.01% | 558 |
|
|
2016
Q3 | $242K | Buy |
+144,000
| New | +$176K | ﹤0.01% | 571 |
|
|
2016
Q1 | – | Sell |
-275,000
| Closed | -$333K | – | 606 |
|
|
2015
Q4 | $333K | Hold |
275,000
| – | – | ﹤0.01% | 557 |
|
|
2015
Q3 | $468K | Hold |
275,000
| – | – | ﹤0.01% | 536 |
|
|
2015
Q2 | $572K | Hold |
275,000
| – | – | ﹤0.01% | 543 |
|
|
2015
Q1 | $745K | Hold |
275,000
| – | – | 0.01% | 502 |
|
|
2014
Q4 | $707K | Sell |
275,000
-2,000
| -0.7% | -$4.49K | 0.01% | 506 |
|
|
2014
Q3 | $507K | Hold |
277,000
| – | – | ﹤0.01% | 534 |
|
|
2014
Q2 | $740K | Hold |
277,000
| – | – | 0.01% | 481 |
|
|
2014
Q1 | $1.01M | Buy |
+277,000
| New | +$1.23M | 0.01% | 436 |
|
Other funds holding ATRS
CIBC Private Wealth Group's ATRS Position: Q2 2022 in Review
CIBC Private Wealth Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 125,000 shares — an estimated $513K sold.
CIBC Private Wealth Group first reported a position in ATRS in Q1 2014 and held it in 31 quarters. The position peaked at $1.01M in Q1 2014. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- CIBC Private Wealth Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- CIBC Private Wealth Group sold 125,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $513K.
- CIBC Private Wealth Group first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 31 quarters.
- CIBC Private Wealth Group's Antares Pharma, Inc. position peaked at $1.01M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on CIBC Private Wealth Group's 13F filing for Q2 2022, filed 3 Aug 2022.